• 尊龙凯时·(中国区)人生就是搏!

    About HEC
    High-tech light
    About HEC
    High-tech light

    Development Path

    2023

    · HEC, an A-share listed company (600673.SH), Zunyi Municipal Government and GAC Group reached a strategic cooperation to improve the layout of the new energy industry
    · HEC Pharm R&D Center was restructured and renamed Sunshine Lake Pharma Co., Ltd. ("HEC Pharma")

    2022

    ·The construction of Zhejiang Dongyang base was started, with a total investment of 20 billion yuan
    ·Low-carbon high-end battery aluminum foil project started construction in Yichang, Hubei

    2021

    ·HEC Pharmaceutical Research Institute completed A round of financing of nearly 7 billion yuan
    ·HEC Pharmaceutical Research Institute completed the equity control of  HEC Changjiang Pharmaceutical (01558.HK), realizing the integration of pharmaceutical assets

    2020

    ·Mr. Zhang Yushuai took over as chairman of HEC Group and established a new board of directors of HEC Group. HEC officially entered the 2.0 new era of "co-creation, co-responsibility and sharing"
    ·HEC's first Class 1.1 original innovative drug "Emitasvir Phosphate" was approved for marketing

    2019

    The annual sales of anti-influenza drug Kewei reached nearly 7 billion yuan, setting a new high for similar anti-influenza drug products in China

    2018

    ·Cordyceps sinensis (breeding product) was included in "Guangdong Province Local Medicinal Materials Standard" (Volume 3)
    ·"Research on key technologies of Cordyceps sinensis breeding and its industrial application" won the first prize of Guangdong Science and Technology Progress Award

    2017

    The construction of the Ulanchap base in Inner Mongolia started with an investment of nearly 2 billion yuan

    2016

    HEC Health Research Institute was approved by the State Administration of Traditional Chinese Medicine to establish the "Key Research Laboratory of Cordyceps Sinensis Breeding and Product Research and Development"

    2015

    ·HEC Changjiang Pharmaceutical was listed on the main board of Hong Kong, stock code: 01558.HK
    ·HEC Pharmaceutical Research Institute is approved by the Ministry of Science and Technology of the People's Republic of China to establish a "State Key Laboratory of New Anti-infective Drug Research and Development"

    2014

    The construction of the Nyingchi base in Tibet began, which is a supporting base for the ecological breeding of Cordyceps sinensis

    2013

    A-share listed company HEC (600673.SH) issued additional private placements to expand the medium and high pressure formed foil project and the high specific volume corrosion foil project

    2012

    Took the lead in realizing the industrialization of Cordyceps sinensis ecological breeding in the world

    2011

    HEC's first generic drug approved by the U.S. FDA, Zidovudine Tablets for the treatment of AIDS, was on the market

    2010

    Shaoguan started the construction of pharmaceutical industry projects

    2009

    Provided oseltamivir phosphate reserve drug for the country's prevention and control of influenza epidemic, and commended by the National Development and Reform Commission

    2008

    Started the process of internationalization of preparations

    2007

    New electronic material assets were injected into A-share listed company HEC (600673.SH)

    2006

    Obtained the exclusive authorization of Roche's "Oseltamivir Phosphate"

    2005

    HEC a comprehensive and systematic research institute was established

    2004

    Zunyi Base in Guizhou  started construction

    2003

    ·HEC A-share backdoor listing, stock code: 600673.SH
    ·Dongguan Songshan Lake Factory started construction

    2002

    ·Guangdong Dongguan Base started construction
    ·Acquired Hubei Changhe Pharmaceutical Co., Ltd. and officially entered the pharmaceutical industry

    2001

    Yichang base in Hubei started construction

    2000

    "Low-voltage and high-volume formed foil" was included in the "Double High and One Excellent" project-oriented plan of the State Economic and Trade Commission's national key technological transformation

    1999

    HEC fully implemented the management of the general outline system, and the first edition of the "Outline of Work" was officially published and released

    1998

    The construction of Shaoguan base in Guangdong began, focusing on the development of electronic materials industry

    1997

    Mr. Zhang Zhongneng founded HEC Group
    友情链接: